1-2 of 2
Narcisse Elenga, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Frédéric Galactéros, MDPhD, Ersi Voskaridou, Anoosha Habibi, MD PhD, Giovanna Cannas, MD, Laure Joseph, MD, Gylna Loko, MD, Mariane De Montalembert, MD PhD, Narcisse Elenga, MD PhD, Malika Benkerrou, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4–5.
https://doi.org/10.1182/blood-2020-140265
Published: 2020
Journal Articles

Overview of Growth Development in Pediatric Patients Treated with Hydroxyurea (HU) in the Escort-HU Study

Lena Oevermann, MD, Mariane De Montalembert, MD PhD, Malika Benkerrou, MD, Valentine Brousse, MD, Corinne Pondarré, MD PhD, Marie Petras, MD, Marie Belloy, MD, Narcisse Elenga, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1079.
https://doi.org/10.1182/blood-2018-99-114441
Published: 2018